newsfilter
← Latest News
ACCESS Newswire·

US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher

SHELTON, CT / ACCESS Newswire / June 29, 2026 / NanoViricides, Inc., a publicly traded company , and a clinical stage, leading global pioneer in the development of broad-spectrum